The beta-blocker

Eyebrows were raised when Doug Dachille – a finance prodigy with a fearsome trading reputation on Wall Street – became chief operating officer of Zurich Capital Markets (ZCM) in April. Why, many asked, would JP Morgan Chase’s ex-global head of proprietary trading, who quit the firm once he realised Chase’s credit risk business model was prevailing over that of legacy JP Morgan’s, join an institution whose parent, Zurich Financial, faced major losses? Dachille’s answer: to build the world’s

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

If you already have an account, please sign in here.

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here